Medical Beauty Research Appoints Julia Schwieger as Chief Financial Officer

Julia Schwieger assumed the role of Chief Financial Officer at Medical Beauty Research (MBR) on September 1, 2026. In her new position, she is responsible for Finance, Controlling and Corporate Development.

Aue Bad-Schlema, Germany — September, 2026

Schwieger joins MBR with experience from companies that have helped create and shape new markets, working closely with CEOs and owners throughout her career. She brings extensive expertise in building, leading and strategically managing finance organizations in an international environment.

“MBR has something that cannot be bought: decades of formulation expertise and clients who understand exactly what they are investing in. In markets that are only just taking shape, the companies that define them are determined early. That is what I intend to work on.”
— Julia Schwieger, Chief Financial Officer of Medical Beauty Research

Most recently, she led the group finance function at KONUX, an AI company specializing in railway infrastructure, and previously at Munich-based technology company holoride. At Flix, she headed finance for the U.S. business and played a key role in both organic and inorganic growth initiatives, including the acquisition of Greyhound in the United States.

Across these roles, one principle remained consistent: business models centered around the customer, with data serving as a key foundation for decision-making and performance management. Schwieger has lived and worked in Germany, Spain and the United States.

MBR develops and manufactures exclusively in Germany and creates its formulations in collaboration with dermatologists and aesthetic medical professionals, with skin function as the guiding principle. Its products are used in medical-aesthetic environments and distributed in more than 30 countries worldwide.

“Skin is a central element of health. It has guided the way we formulate since the company was founded. Julia Schwieger has worked with companies that transformed emerging markets into global businesses. That experience will be critical to the next phase of MBR.”
— Stefan Kalmund, CEO of Medical Beauty Research

About MBR

MBR Medical Beauty Research develops high-performance skincare systems rooted in German formulation discipline and scientific rigor. MBR is distributed in over 50 countries and serves premium clients and professional partners worldwide.

Press Contact

Viktoria Wolff
Head of Marketing
MBR Skin GmbH
press@mbrskin.com